Company environment · Targeted small molecules · FDA CDER & EMA
A targeted cancer pill and its patient test
Original application and later supplements. Start at the top to see what the company does, then the jobs AI models were given here and how each scored.
1What does this company do?
A drug company with a targeted pill for cancers driven by a specific gene change.
Patients qualify only if a test finds the gene change, so the drug’s evidence, its label and the testing strategy must line up.
2Where is the product on its way to patients?
Filed for approval, then filed again for new uses in the US and Europe.
- 1Discovery
- 2Lab & animal studies
- 3Human trials
- 4Filing & review
- The product is here
- 5Approved
- 6On the market
Jobs sit at the original filing, a later US supplement, and a European variation.
3What is happening right now?
A filing committee meets tomorrow, and the working files contradict each other.
The team must decide what each dated body of evidence supports and produce a conclusion someone can sign.
4Which jobs were the models given?
5 jobs, each graded against a specialist’s checklist.
Scores are checks passed out of checks in the list. Each model ran each job once.
5–7Evidence, work and verdict
This company’s files stay private.
It is built from a real product’s records, so its files, runs and checklists aren’t published. To follow a job all the way down to each check, open one of the public environments.
Havenor Therapeutics (fictional, fully published) →
Broad Institute (real, public FDA record) →